Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes

Author： Sindelar J.L. Jofre-Bonet M. French M.T. McLellan A.T.

Publisher： Elsevier

ISSN： 0376-8716

Source： Drug and Alcohol Dependence, Vol.73, Iss.1, 2004-01, pp. : 41-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B

By Crowley S.J.

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 409-427

Adis International

Access to resources Recommend Favorite

Proton Pump Inhibitors in Acute Treatment of Reflux Oesophagitis: A Cost-Effectiveness Analysis

By Lucioni C.

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 325-336

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan

By Shimbo T.

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 875-886

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Rizatriptan and Sumatriptan versus Cafergot ® in the Acute Treatment of Migraine

By Zhang Lihua Hay Joel W.

CNS Drugs, Vol. 19, Iss. 7, 2005-01 ,pp. : 635-642

Adis International

Access to resources Recommend Favorite